Skip to content

The dose of oxytocin needed to contract uterus after delivery of baby during cesarean section, when using the dose according to weight of patient

Weight-based oxytocin infusion for preventing uterine atony during cesarean section in non-laboring patients: A dose-response study - None

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021862
Enrollment
55
Registered
2019-11-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O721- Other immediate postpartum hemorrhage

Interventions

Intervention1: Dose of oxytocin (1 out of 5): The various doses of oxytocin will include, 0.1 IU/kg/hr, or 0.15 IU/kg/hr, 0.2 IU/kg/hr, 0.25 IU/kg/hr, or 0.3 IU/kg/hr Control Intervention1: nil: nil

Sponsors

University College of Medical Sciences and GTB Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Non-laboring parturients with no risk factors for increasing uterine atony, and posted for cesarean section under spinal block.

Exclusion criteria

Exclusion criteria: patient refusal, presence of labor, use of preoperative oxytocin for labor induction/augmentation,preterm gestational age, any risk factor for uterine atony including multiple gestation, polyhydramnios, macrosomia, history of PPH or previous uterine surgery or bleeding disorders, high parity, chorioamnionitis, uterine rupture, preeclampsia, and presence of abnormal placentation or uterine fibroids, contraindication to spinal block.

Design outcomes

Secondary

MeasureTime frame
Side effects of oxytocin: a) Hypotension, b) Tachycardia, c) Lead II electrocardiographic ST-T changes, d) Nausea/vomiting, e) Flushing, and f) Chest pain. Timepoint: after start of oxytocin infusion till till end of surgery or prior to rescue bolus whichever is earlier.

Primary

MeasureTime frame
adequate uterine tone (assessed by the surgeon) Timepoint: 4 minutes after initiation of oxytocin, and entire subsequent time till skin closure.

Countries

India

Contacts

Public ContactSURBHI TYAGI

University College of Medical Sciences and GTB Hospital

drashatyagi@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026